{"id":3845,"date":"2018-12-17T11:58:35","date_gmt":"2018-12-17T11:58:35","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\/"},"modified":"2018-12-17T11:58:35","modified_gmt":"2018-12-17T11:58:35","slug":"nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\/","title":{"rendered":"Nanexa skriver avtal med l\u00e4kemedelsf\u00f6retag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><span><strong><\/strong><\/span><\/p>\n<\/div>\n<p><span>Ett svenskt noterat l\u00e4kemedelsbolag p\u00e5b\u00f6rjar utv\u00e4rdering av Nanexas drug delivery-plattform PharmaShell\u00ae\u00a0som en m\u00f6jlig teknologi att anv\u00e4nda i ett specifikt produktutvecklingsprojekt. Utv\u00e4rderingen som regleras av ett\u00a0\u201dMaterial Transfer and Feasibility study agreement\u201d\u00a0startar inom kort.<\/span><\/p>\n<p><span>Utv\u00e4rderingsarbetet inleds med en\u00a0in vitro-studie som i ett andra steg planeras f\u00f6ljas upp med en\u00a0in vivo-studie . Arbetet kommer ligga till grund f\u00f6r f\u00f6rhandling om ett ut\u00f6kat kommersiellt avtal r\u00f6rande PharmaShell\u00ae.<\/span><\/p>\n<p><span>I det nu \u00f6verenskomna samarbetet erh\u00e5ller Nanexa \u00f6verenskomna mindre betalningar vid signering, leverans av\u00a0in vitro-resultat samt vid leverans av material till en\u00a0in vivo-studie. Det svenska l\u00e4kemedelsbolaget som Nanexa tecknat avtal med bekostar \u00e4ven den\u00a0in vivo-studiesom planeras inom ramen f\u00f6r utv\u00e4rderingen.<\/span><\/p>\n<p><span>Nanexas VD David Westberg kommenterar:<\/span><\/p>\n<p><span>Det arbete vi systematiskt lagt ner p\u00e5 utveckling och marknadsf\u00f6ring av PharmaShell\u00ae\u00a0b\u00f6rjar nu ge resutat. Denna g\u00e5ng \u00e4r det ett svenskt l\u00e4kemedelsbolag som valt att utv\u00e4rdera PharmaShell\u00ae\u00a0f\u00f6r ett specifikt produktutvecklingsprojekt. Det \u00e4r givetvis oerh\u00f6rt gl\u00e4djande och vi ser fram emot att arbeta med ytterligare ett f\u00f6retag som vill utv\u00e4rdera v\u00e5r teknologiplattform.<\/span><\/p>\n<p><span>F\u00f6r mer information kontakta:<br \/>David Westberg\u00a0\u2013\u00a0VD, Nanexa AB (publ)\u00a0Telefon: 0709 &#8211; 42 83 03<br \/>E-post: david.westberg@nanexa.se www.nanexa.com<\/span><\/p>\n<p><span>Denna information \u00e4r s\u00e5dan information som Nanexa AB \u00e4r skyldigt att offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande den 17 december, 2018.<\/span><\/p>\n<p><span>Om Nanexa AB (publ)<\/span><\/p>\n<p><span>Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell\u00ae\u00a0som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae\u00a0har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/span><\/p>\n<p><\/p>\n<p><span><strong><\/strong><\/span><\/p>\n<p><\/p>\n<p><span><strong><\/strong><\/span><\/p>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/mb.cision.com\/Main\/12591\/2702328\/964591.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Read as PDF<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<\/p>\n<p>Ett svenskt noterat l\u00e4kemedelsbolag p\u00e5b\u00f6rjar utv\u00e4rdering av Nanexas drug delivery-plattform PharmaShell\u00ae\u00a0som en m\u00f6jlig teknologi att anv\u00e4nda i ett specifikt produktutvecklingsprojekt. Utv\u00e4rderingen som regleras av ett\u00a0\u201dMaterial Transfer and Feasibility study agreement\u201d\u00a0startar inom kort.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"template":"","class_list":["post-3845","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-ci-sales_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-mar_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-sales-order_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa skriver avtal med l\u00e4kemedelsf\u00f6retag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa skriver avtal med l\u00e4kemedelsf\u00f6retag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Ett svenskt noterat l\u00e4kemedelsbolag p\u00e5b\u00f6rjar utv\u00e4rdering av Nanexas drug delivery-plattform PharmaShell\u00ae\u00a0som en m\u00f6jlig teknologi att anv\u00e4nda i ett specifikt produktutvecklingsprojekt. Utv\u00e4rderingen som regleras av ett\u00a0\u201dMaterial Transfer and Feasibility study agreement\u201d\u00a0startar inom kort.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\\\/\",\"name\":\"Nanexa skriver avtal med l\u00e4kemedelsf\u00f6retag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2018-12-17T11:58:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa skriver avtal med l\u00e4kemedelsf\u00f6retag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa skriver avtal med l\u00e4kemedelsf\u00f6retag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa skriver avtal med l\u00e4kemedelsf\u00f6retag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB","og_description":"Ett svenskt noterat l\u00e4kemedelsbolag p\u00e5b\u00f6rjar utv\u00e4rdering av Nanexas drug delivery-plattform PharmaShell\u00ae\u00a0som en m\u00f6jlig teknologi att anv\u00e4nda i ett specifikt produktutvecklingsprojekt. Utv\u00e4rderingen som regleras av ett\u00a0\u201dMaterial Transfer and Feasibility study agreement\u201d\u00a0startar inom kort.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\/","name":"Nanexa skriver avtal med l\u00e4kemedelsf\u00f6retag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2018-12-17T11:58:35+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-skriver-avtal-med-lakemedelsforetag-for-utvardering-av-pharmashell\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa skriver avtal med l\u00e4kemedelsf\u00f6retag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3845","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}